Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy

被引:45
|
作者
Mezzatesta, M. L. [1 ]
D'Andrea, M. M. [2 ]
Migliavacca, R. [3 ]
Giani, T. [2 ]
Gona, F. [1 ]
Nucleo, E. [3 ]
Fugazza, G. [3 ]
Pagani, L. [3 ]
Rossolini, G. M. [2 ,3 ,4 ]
Stefani, S. [1 ]
机构
[1] Univ Catania, Dept Microbiol, I-95124 Catania, Italy
[2] Univ Siena, Dept Mol Biol, Microbiol Sect, I-53100 Siena, Italy
[3] Univ Pavia, Dept Microbiol, I-27100 Pavia, Italy
[4] Azienda Osped Univ Senese, Dipartimento Serv, UOC Microbiol & Virol, Siena, Italy
关键词
Acinetobacter baumannii; carbapenemases; MLST; PFGE; tigecycline; FIELD GEL-ELECTROPHORESIS; EUROPEAN CLONE-II; CARE-UNIT PATIENTS; ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; HOSPITAL OUTBREAK; TYPING SCHEME; IDENTIFICATION; EMERGENCE; INFECTIONS;
D O I
10.1111/j.1469-0691.2011.03527.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study was aimed at tracing the molecular characteristics of carbapenem-resistant Acinetobacter baumannii (CRAB) clinical isolates in Italy with both pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). Two hundred and two CRAB isolates were collected during 20042009, in two different surveillance periods, from 22 Italian hospitals that were representative for both distribution and infection. PFGE was performed, and the MLST scheme used was based on the gene sequence as published on the MLST Pasteur website . Representatives of the major European clones similar to I (RUH similar to 875) and II (RUH similar to 134) were used as controls. The two groups of isolates were characterized for their carbapenem resistance genes: 154 of 202 carried blaOXA-58 alone, 21 of 202 also carried blaOXA-23, and 27 of 202 carried blaOXA-23 alone. No isolates were positive for blaOXA-24. Genotype analysis of all isolates identified four distinct patterns by PFGE, which correlated with four distinct sequence types (STs) by MLST. The distribution of these four clusters in Italy confirmed the propensity of A.similar to baumannii for nosocomial cross-transmission in a vast geographical area. We observed that clones similar to A and B had similarities with European clone similar to II and I respectively. By MLST, clone similar to A was ST2, like European clone similar to II, and clone similar to B was ST1, like European clone similar to I. PFGE and MLST showed the same discriminatory power and reproducibility. In addition, the two methods were concordant in defining CRAB Italian clones and in correlating them with the two pan-European clones.
引用
收藏
页码:160 / 166
页数:7
相关论文
共 50 条
  • [31] Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms
    Skalweit, Marion J.
    Li, Mei
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3013 - 3020
  • [32] Molecular and Epidemiological Characterization of Carbapenem-Resistant Acinetobacter baumannii in Non-Tertiary Korean Hospitals
    Park, Sunok
    Kim, Hwa-Su
    Lee, Kyeong Min
    Yoo, Jung Sik
    Yoo, Jae Il
    Lee, Yeong Seon
    Chung, Gyung Tae
    [J]. YONSEI MEDICAL JOURNAL, 2013, 54 (01) : 177 - 182
  • [33] Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital
    Elabd, Faten M.
    Al-Ayed, Mohamed S. Z.
    Asaad, Ahmed M.
    Alsareii, Saeed A.
    Qureshi, Mohamed A.
    Musa, Hassan A. -A.
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2015, 8 (03) : 242 - 247
  • [34] Colistin heteroresistance in carbapenem-resistant Acinetobacter baumannii clinical isolates from a Thai university hospital
    Khin Thet Thet
    Kamonwan Lunha
    Arpasiri Srisrattakarn
    Aroonlug Lulitanond
    Ratree Tavichakorntrakool
    Waewta Kuwatjanakul
    Nicha Charoensri
    Aroonwadee Chanawong
    [J]. World Journal of Microbiology and Biotechnology, 2020, 36
  • [35] Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates
    Vijayakumar, Saranya
    Swetha, Rayapadi G.
    Bakthavatchalam, Yamuna Devi
    Vasudevan, Karthick
    Abirami Shankar, Baby
    Kirubananthan, Agilandeeswari
    Walia, Kamini
    Ramaiah, Sudha
    Biswas, Indranil
    Veeraraghavan, Balaji
    Anbarasu, Anand
    [J]. MICROBIOLOGY SPECTRUM, 2024, 12 (02):
  • [36] Detection of the blaVIM-2 Gene in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates in Sudan
    Mohamed, Salma
    Ahmed, Zainab
    Mubarak, Tajalseer
    Mohamed, Sara
    Higazi, Hassan
    Ali, Sara
    [J]. INTERNATIONAL JOURNAL OF BIOMEDICINE, 2022, 12 (04) : 636 - 639
  • [37] Investigation of Metallo-Beta-Lactamase Production in Carbapenem-resistant Clinical Acinetobacter baumannii Isolates
    Tufekci, Enis Fuat
    Alkateeb, Anfal
    Kilinc, Cetin
    Yasar Durmus, Melike
    Baloglu, Mehmet Cengiz
    Celik Altunoglu, Yasemin
    Coplu, Nilay
    [J]. FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2022, 27 (04): : 627 - 636
  • [38] Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe
    Goic-Barisic, Ivana
    Music, Martina Seruga
    Drcelic, Marina
    Tuncbilek, Semra
    Akca, Gulcin
    Jakovac, Sanja
    Tonkic, Marija
    Hrenovic, Jasna
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 33 : 26 - 30
  • [39] Global spread of carbapenem-resistant Acinetobacter baumannii
    Higgins, Paul G.
    Dammhayn, Cathrin
    Hackel, Meredith
    Seifert, Harald
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (02) : 233 - 238
  • [40] Carbapenem-resistant Acinetobacter baumannii in the Republic of Belarus
    Gorbich, Yury
    Karpov, Igor
    Edelstein, Mikhail
    Martinovich, Alexey
    Kretchikova, Olga
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (03) : 201 - 202